West Virginia State Rheumatology Society
J

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

By West Virginia State Rheumatology Society FEATURING Jean Bustamante
By West Virginia State Rheumatology Society FEATURING Jean Bustamante
0 views
June 26, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

02:35
UCB Rheumatology

Staying Curious and Rising to the Challenge

Feat. I. Mcinnes

Featured Video

18:08
Genentech & Novartis

Shared Voices in the CSU Community

Feat. S. Gawchik

Recommended

AUTOPLAY
08:49
David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

35:40
Balazs Halmos

Year in Review: Lung Cancer

17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
22:08
RheumNow

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

Feat. J. Cush
18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
12:46
Stanford Medicine

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Feat. A. Betof Warner
22:06
Masterclasses in Dermatology

Hair Graying and the Melanocyte: Mechanisms and Melanoma Implications

Feat. D. Fisher
24:14
Masterclasses in Dermatology

Advances in the Treatment of Melanoma

Feat. D. Fisher
26:31
Cleveland Clinic Rheumatology

Clinical Approach to Diagnosis and Treatment of Cytokine Storm in Rh…

Feat. R. Q. Cron
36:14
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

Feat. B. Halmos
29:25
Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
09:00
AAD 2024 Insights

AAD 2024 Insights: What's New In Nail Tumors

Feat. J. Dominguez-Cherit
14:49
Vivek Subbiah

Year in Review: Precision Medicine

13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez
29:43
Michigan Medicine

GI and Hepatic Complications of Cancer Immunotherapy

Feat. R. Fontana
32:45
NYU Langone

Checkpoint Inhibitors and Rheumatic Disease

Feat. A. Bass
11:05
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, …

Feat. D. Johnson
18:57
Masterclasses in Dermatology

Safety and Monitoring Considerations in Systematic Therapy

Feat. J. Cohen